Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 10.3389/fphar.2016.00199 Pharmacology Retraction Retraction: Mechanism of Action of the Novel Nickel(II) Complex in Simultaneous Reactivation of the Apoptotic Signaling Networks Against Human Colon Cancer Cells Frontiers in Pharmacology Editorial Office *

Approved by: Théophile Godfraind, Université Catholique de Louvain, Belgium

*Correspondence: Frontiers in Pharmacology Editorial Office pharmacology.editorial.office@frontiersin.org

This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology

 29 06 2016 2016 7 199 22 06 2016 22 06 2016 Copyright © 2016 Frontiers in Pharmacology Editorial Office. 2016 Frontiers in Pharmacology Editorial Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A retraction of the Original Research Article Mechanism of Action of the Novel Nickel(II) Complex in Simultaneous Reactivation of the Apoptotic Signaling Networks Against Human Colon Cancer Cells by Samie, N., Haerian, B. S., Muniandy, S., Marlina, A., Kanthimathi, M. S., Abdullah, N. B., et al. (2016). Front. Pharmacol. 6:313. doi: 10.3389/fphar.2015.00313

The Journal and Authors retract the 28 January 2016 article cited above for the following reasons: Following online criticisms of the published paper, an investigation at the journal has confirmed the manipulation and duplication of data, and a level of image processing that is not compliant with the journal’s policies on image data integrity.

Further, a post-publication cross-check screening revealed significant overlap with another manuscript submitted by the authors to another journal. While all manuscripts submitted to Frontiers undergo cross-check screening, the article cited below was in review in parallel with the Frontiers article and thus the overlap was not apparent until publication (Samie et al., 2016).

References Samie N. Muniandy S. Kanthimathi M. S. Haerian B. S. (2016). Mechanism of action of novel piperazine containing a toxicant against human liver cancer cells. PeerJ. 4:e1588. 10.7717/peerj.158827019772